Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy

Novel technologies are being developed to improve patient therapy through the identification of targets and surrogate molecular signatures that can help direct appropriate treatment regimens for efficacy and drug safety. This is particularly the case in oncology whereby patient tumor and biofluids a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolaides, Nicholas C., O’Shannessy, Daniel J., Albone, Earl, Grasso, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056284/
https://www.ncbi.nlm.nih.gov/pubmed/24982846
http://dx.doi.org/10.3389/fonc.2014.00141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056284/
https://www.ncbi.nlm.nih.gov/pubmed/24982846
http://dx.doi.org/10.3389/fonc.2014.00141

Ejemplares similares